Stock Market & Financial Investment News

News Breaks December 21, 2012 15:28 EDT ALXA Alexza Pharmaceuticals' Adasuve approved by FDA Alexza Pharmaceuticals announced that the FDA approved Adasuve Inhalation Powder 10 mg for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults. Adasuve combines Alexza's proprietary Staccato delivery system with the antipsychotic drug, loxapine. News For ALXA From The Last 14 Days Check below for free stories on ALXA the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 22, 2013 16:23 EDT ALXA Alexza Pharmaceuticals chief commercial officer to leave company Subscribe for More Information May 14, 2013 16:13 EDT ALXA Alexza Pharmaceuticals reports Q1 EPS ($1.31), consensus (45c) Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.